1. Home
  2. NUVL vs TKR Comparison

NUVL vs TKR Comparison

Compare NUVL & TKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$104.60

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Logo Timken Company (The)

TKR

Timken Company (The)

HOLD

Current Price

$117.83

Market Cap

7.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
TKR
Founded
2017
1899
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
7.6B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
NUVL
TKR
Price
$104.60
$117.83
Analyst Decision
Strong Buy
Buy
Analyst Count
16
7
Target Price
$134.75
$118.29
AVG Volume (30 Days)
506.3K
808.3K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
1.31%
EPS Growth
N/A
N/A
EPS
N/A
1.40
Revenue
N/A
$80,100,000.00
Revenue This Year
N/A
$4.57
Revenue Next Year
$1,239.49
$3.97
P/E Ratio
N/A
$84.46
Revenue Growth
N/A
N/A
52 Week Low
$70.25
$67.14
52 Week High
$113.02
$123.67

Technical Indicators

Market Signals
Indicator
NUVL
TKR
Relative Strength Index (RSI) 53.04 65.03
Support Level $97.91 $94.50
Resistance Level $107.49 N/A
Average True Range (ATR) 3.83 3.62
MACD -0.18 0.94
Stochastic Oscillator 56.63 68.21

Price Performance

Historical Comparison
NUVL
TKR

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About TKR Timken Company (The)

The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The various products offered by the company include ball bearings, plain bearings, tapered roller bearings, housed bearings, linear guides, telescopic rails, lubrication systems, agricultural conveyor chains, couplings, brakes, seals, etc. These products are offered through brands like Timken, GGB, Philadelphia Gear, Cone Drive, CGI, and Rollon, among others. The company has two reportable segments: Engineered Bearings, which generates the maximum revenue, and Industrial Motion. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Africa (EMEA), Asia-Pacific, and the other regions of the Americas.

Share on Social Networks: